Teva, Baxter Hit With $500M Damages In Hepatitis Case
By Hilary Russ ( May 7, 2010, 6:40 PM EDT) -- U.S. subsidiaries of Teva Pharmaceuticals Industries Ltd. and Baxter International Inc. reportedly have been hit with a $500 million punitive damages award in the first suit among hundreds to go to trial after an outbreak of hepatitis C in 2008 that plaintiffs say was spread because vials of an anesthetic were mislabeled....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.